| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Models, Genetic | 59 | 2024 | 3449 | 4.580 |
Why?
|
| Genome-Wide Association Study | 79 | 2023 | 12807 | 3.280 |
Why?
|
| Polymorphism, Single Nucleotide | 92 | 2024 | 16047 | 2.480 |
Why?
|
| Genetic Predisposition to Disease | 86 | 2024 | 18071 | 2.260 |
Why?
|
| Linkage Disequilibrium | 37 | 2019 | 1997 | 2.220 |
Why?
|
| Family | 31 | 2020 | 3209 | 2.080 |
Why?
|
| Genetic Association Studies | 15 | 2020 | 2741 | 1.890 |
Why?
|
| Computer Simulation | 40 | 2023 | 6255 | 1.800 |
Why?
|
| Antitubercular Agents | 13 | 2019 | 1384 | 1.610 |
Why?
|
| Pulmonary Disease, Chronic Obstructive | 34 | 2023 | 3247 | 1.580 |
Why?
|
| Nuclear Family | 9 | 2017 | 311 | 1.540 |
Why?
|
| Genetics, Population | 13 | 2017 | 943 | 1.510 |
Why?
|
| Genetic Markers | 23 | 2016 | 2601 | 1.500 |
Why?
|
| Asthma | 53 | 2023 | 6270 | 1.400 |
Why?
|
| Genetic Linkage | 16 | 2019 | 2341 | 1.400 |
Why?
|
| Genome, Human | 25 | 2019 | 4448 | 1.380 |
Why?
|
| Genetic Pleiotropy | 2 | 2022 | 182 | 1.200 |
Why?
|
| Quantitative Trait, Heritable | 14 | 2013 | 541 | 1.170 |
Why?
|
| Models, Statistical | 21 | 2018 | 5089 | 1.160 |
Why?
|
| Quantitative Trait Loci | 14 | 2016 | 2140 | 1.160 |
Why?
|
| Software | 15 | 2019 | 4462 | 1.130 |
Why?
|
| Phenotype | 49 | 2023 | 16721 | 1.100 |
Why?
|
| Genome | 5 | 2024 | 1753 | 1.100 |
Why?
|
| Mycobacterium tuberculosis | 16 | 2018 | 1917 | 1.080 |
Why?
|
| Tuberculosis, Multidrug-Resistant | 7 | 2019 | 942 | 1.020 |
Why?
|
| Mendelian Randomization Analysis | 2 | 2022 | 1044 | 1.010 |
Why?
|
| Genetic Variation | 22 | 2022 | 6610 | 1.010 |
Why?
|
| Molecular Epidemiology | 7 | 2021 | 471 | 0.980 |
Why?
|
| Gene Frequency | 28 | 2023 | 3624 | 0.950 |
Why?
|
| Cluster Analysis | 8 | 2022 | 2721 | 0.950 |
Why?
|
| Tuberculosis, Pulmonary | 7 | 2018 | 838 | 0.920 |
Why?
|
| Multifactorial Inheritance | 5 | 2024 | 1425 | 0.920 |
Why?
|
| Extensively Drug-Resistant Tuberculosis | 4 | 2018 | 85 | 0.880 |
Why?
|
| Alzheimer Disease | 21 | 2024 | 8730 | 0.860 |
Why?
|
| DNA Methylation | 4 | 2024 | 4424 | 0.840 |
Why?
|
| Genetic Testing | 12 | 2013 | 3595 | 0.840 |
Why?
|
| Apolipoproteins E | 5 | 2024 | 1458 | 0.820 |
Why?
|
| Algorithms | 25 | 2024 | 14071 | 0.820 |
Why?
|
| Genomics | 10 | 2024 | 5929 | 0.800 |
Why?
|
| Haplotypes | 18 | 2017 | 2728 | 0.780 |
Why?
|
| Genotype | 48 | 2015 | 13024 | 0.740 |
Why?
|
| Genetic Loci | 11 | 2023 | 2631 | 0.720 |
Why?
|
| Chromosome Mapping | 11 | 2014 | 4618 | 0.700 |
Why?
|
| Multiple Organ Failure | 1 | 2023 | 390 | 0.700 |
Why?
|
| Cleft Lip | 7 | 2014 | 511 | 0.700 |
Why?
|
| Pedigree | 15 | 2019 | 4526 | 0.690 |
Why?
|
| Latent Tuberculosis | 4 | 2015 | 223 | 0.660 |
Why?
|
| Clofazimine | 2 | 2018 | 39 | 0.660 |
Why?
|
| Sequence Analysis, DNA | 9 | 2017 | 4772 | 0.650 |
Why?
|
| Data Interpretation, Statistical | 9 | 2022 | 2686 | 0.630 |
Why?
|
| Tuberculosis | 10 | 2016 | 2012 | 0.620 |
Why?
|
| Receptor, Angiotensin, Type 2 | 1 | 2018 | 61 | 0.610 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 6 | 2024 | 3797 | 0.610 |
Why?
|
| Genetic Techniques | 4 | 2011 | 429 | 0.590 |
Why?
|
| Pulmonary Aspergillosis | 1 | 2018 | 48 | 0.580 |
Why?
|
| Humans | 224 | 2024 | 765968 | 0.570 |
Why?
|
| Genome, Viral | 1 | 2021 | 670 | 0.540 |
Why?
|
| Cleft Palate | 5 | 2014 | 591 | 0.540 |
Why?
|
| Databases, Genetic | 7 | 2021 | 1751 | 0.530 |
Why?
|
| Gene Dosage | 3 | 2008 | 1216 | 0.490 |
Why?
|
| Bronchi | 3 | 2018 | 843 | 0.490 |
Why?
|
| Case-Control Studies | 40 | 2022 | 22223 | 0.490 |
Why?
|
| Forced Expiratory Volume | 12 | 2022 | 1828 | 0.450 |
Why?
|
| Thiophenes | 1 | 2018 | 569 | 0.450 |
Why?
|
| Environment | 3 | 2010 | 1114 | 0.420 |
Why?
|
| Bronchoscopy | 2 | 2018 | 909 | 0.410 |
Why?
|
| Proportional Hazards Models | 2 | 2024 | 12509 | 0.410 |
Why?
|
| Principal Component Analysis | 7 | 2023 | 951 | 0.400 |
Why?
|
| Pharmacogenetics | 5 | 2010 | 682 | 0.390 |
Why?
|
| Genetic Diseases, Inborn | 3 | 2010 | 605 | 0.380 |
Why?
|
| Data Compression | 1 | 2012 | 69 | 0.380 |
Why?
|
| Smoking | 12 | 2022 | 9081 | 0.360 |
Why?
|
| Alleles | 15 | 2020 | 6897 | 0.360 |
Why?
|
| Immunoassay | 2 | 2014 | 741 | 0.360 |
Why?
|
| Aorta | 1 | 2018 | 2028 | 0.350 |
Why?
|
| Genes | 2 | 2013 | 1825 | 0.350 |
Why?
|
| Biometry | 3 | 2010 | 571 | 0.340 |
Why?
|
| Epigenesis, Genetic | 1 | 2023 | 3819 | 0.340 |
Why?
|
| Receptors, Immunologic | 4 | 2022 | 1415 | 0.330 |
Why?
|
| Attitude | 1 | 2014 | 770 | 0.330 |
Why?
|
| DNA Copy Number Variations | 4 | 2013 | 2045 | 0.310 |
Why?
|
| Aortic Aneurysm, Abdominal | 1 | 2018 | 1211 | 0.310 |
Why?
|
| Sulfonamides | 1 | 2018 | 1984 | 0.310 |
Why?
|
| Rare Diseases | 1 | 2014 | 635 | 0.300 |
Why?
|
| Meta-Analysis as Topic | 2 | 2015 | 1370 | 0.290 |
Why?
|
| Bayes Theorem | 4 | 2022 | 2354 | 0.290 |
Why?
|
| Interleukin-2 | 2 | 2014 | 1896 | 0.290 |
Why?
|
| Selection Bias | 2 | 2022 | 361 | 0.280 |
Why?
|
| Viral Load | 2 | 2016 | 3386 | 0.280 |
Why?
|
| Statistics as Topic | 2 | 2010 | 2352 | 0.270 |
Why?
|
| Male | 89 | 2024 | 363698 | 0.260 |
Why?
|
| Body Mass Index | 9 | 2021 | 13039 | 0.260 |
Why?
|
| Programming Languages | 1 | 2006 | 133 | 0.260 |
Why?
|
| Linear Models | 6 | 2024 | 5876 | 0.250 |
Why?
|
| Child | 49 | 2023 | 80564 | 0.250 |
Why?
|
| Genetics, Medical | 1 | 2008 | 334 | 0.250 |
Why?
|
| Research Design | 6 | 2011 | 6209 | 0.230 |
Why?
|
| Female | 88 | 2024 | 396112 | 0.230 |
Why?
|
| Germany | 4 | 2014 | 882 | 0.230 |
Why?
|
| Models, Theoretical | 3 | 2012 | 3564 | 0.230 |
Why?
|
| HIV Core Protein p24 | 1 | 2004 | 245 | 0.220 |
Why?
|
| Disease-Free Survival | 2 | 2024 | 6832 | 0.220 |
Why?
|
| DNA Probes | 1 | 2024 | 541 | 0.220 |
Why?
|
| Serpin E2 | 4 | 2011 | 48 | 0.220 |
Why?
|
| Probability | 5 | 2019 | 2475 | 0.220 |
Why?
|
| Schizophrenia | 5 | 2015 | 6972 | 0.220 |
Why?
|
| Phylogeny | 2 | 2021 | 2832 | 0.210 |
Why?
|
| Hypersensitivity, Immediate | 2 | 2023 | 346 | 0.210 |
Why?
|
| Europe | 7 | 2021 | 3423 | 0.210 |
Why?
|
| Tuberculin | 2 | 2014 | 63 | 0.210 |
Why?
|
| Polymorphism, Genetic | 10 | 2009 | 4247 | 0.200 |
Why?
|
| Chromosomes, Human, Pair 15 | 5 | 2015 | 360 | 0.200 |
Why?
|
| Dystrophin-Associated Proteins | 1 | 2022 | 60 | 0.190 |
Why?
|
| Bronchodilator Agents | 5 | 2015 | 514 | 0.190 |
Why?
|
| Gene Regulatory Networks | 1 | 2010 | 1748 | 0.190 |
Why?
|
| CpG Islands | 2 | 2024 | 1207 | 0.180 |
Why?
|
| Inheritance Patterns | 3 | 2013 | 345 | 0.180 |
Why?
|
| High-Throughput Nucleotide Sequencing | 2 | 2015 | 3655 | 0.180 |
Why?
|
| Bronchoalveolar Lavage Fluid | 4 | 2011 | 755 | 0.180 |
Why?
|
| Cell Adhesion Molecules | 2 | 2019 | 1612 | 0.170 |
Why?
|
| Emphysema | 1 | 2023 | 234 | 0.170 |
Why?
|
| Gene Expression | 4 | 2023 | 7584 | 0.170 |
Why?
|
| User-Computer Interface | 1 | 2006 | 1405 | 0.170 |
Why?
|
| Pliability | 1 | 2019 | 57 | 0.170 |
Why?
|
| Nerve Tissue Proteins | 3 | 2012 | 4392 | 0.170 |
Why?
|
| HIV Infections | 9 | 2016 | 17533 | 0.170 |
Why?
|
| Computing Methodologies | 2 | 2011 | 17 | 0.170 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 4 | 2020 | 2880 | 0.170 |
Why?
|
| Numerical Analysis, Computer-Assisted | 1 | 2019 | 120 | 0.160 |
Why?
|
| T-Lymphocytes | 2 | 2014 | 10261 | 0.160 |
Why?
|
| alpha-Macroglobulins | 2 | 2010 | 60 | 0.160 |
Why?
|
| Middle Aged | 48 | 2022 | 223009 | 0.160 |
Why?
|
| Tuberculin Test | 3 | 2015 | 205 | 0.160 |
Why?
|
| Suicide | 1 | 2010 | 1604 | 0.160 |
Why?
|
| Paracoccidioidomycosis | 1 | 2018 | 10 | 0.160 |
Why?
|
| Amyloid beta-Protein Precursor | 3 | 2012 | 1116 | 0.150 |
Why?
|
| North America | 2 | 2021 | 1285 | 0.150 |
Why?
|
| Coccidioidomycosis | 1 | 2018 | 36 | 0.150 |
Why?
|
| Pancreatic Elastase | 1 | 2018 | 124 | 0.150 |
Why?
|
| Lung Diseases | 2 | 2019 | 1940 | 0.150 |
Why?
|
| Histoplasmosis | 1 | 2018 | 63 | 0.150 |
Why?
|
| Aspergillus | 1 | 2018 | 93 | 0.150 |
Why?
|
| Interferon Regulatory Factors | 1 | 2019 | 271 | 0.150 |
Why?
|
| Lung | 8 | 2018 | 10033 | 0.140 |
Why?
|
| Epigenomics | 1 | 2023 | 959 | 0.140 |
Why?
|
| Age of Onset | 7 | 2017 | 3344 | 0.140 |
Why?
|
| Pulmonary Emphysema | 1 | 2023 | 683 | 0.140 |
Why?
|
| HIV-1 | 4 | 2013 | 6944 | 0.140 |
Why?
|
| Child Development Disorders, Pervasive | 2 | 2013 | 597 | 0.140 |
Why?
|
| Adult | 45 | 2019 | 223044 | 0.140 |
Why?
|
| Statistics, Nonparametric | 1 | 2003 | 2844 | 0.140 |
Why?
|
| Brazil | 1 | 2021 | 1248 | 0.140 |
Why?
|
| Interferon-gamma | 4 | 2014 | 3160 | 0.140 |
Why?
|
| Physicians | 1 | 2014 | 4588 | 0.130 |
Why?
|
| Vital Capacity | 1 | 2019 | 995 | 0.130 |
Why?
|
| Biostatistics | 1 | 2018 | 162 | 0.130 |
Why?
|
| Multigene Family | 2 | 2013 | 1080 | 0.130 |
Why?
|
| Neuropeptides | 1 | 2022 | 951 | 0.130 |
Why?
|
| Aged | 35 | 2024 | 171117 | 0.130 |
Why?
|
| rac GTP-Binding Proteins | 1 | 2017 | 164 | 0.130 |
Why?
|
| Attention Deficit Disorder with Hyperactivity | 5 | 2008 | 3719 | 0.130 |
Why?
|
| Chromosomes, Human, Pair 14 | 2 | 2014 | 285 | 0.130 |
Why?
|
| Regression Analysis | 4 | 2018 | 6322 | 0.130 |
Why?
|
| Cohort Studies | 20 | 2018 | 41649 | 0.130 |
Why?
|
| Risk | 4 | 2020 | 9591 | 0.130 |
Why?
|
| Transforming Growth Factor beta1 | 2 | 2018 | 637 | 0.130 |
Why?
|
| Pulmonary Medicine | 1 | 2018 | 222 | 0.130 |
Why?
|
| Carrier Proteins | 4 | 2014 | 4913 | 0.130 |
Why?
|
| alpha 1-Antitrypsin Deficiency | 1 | 2016 | 113 | 0.120 |
Why?
|
| Antiretroviral Therapy, Highly Active | 1 | 2004 | 1899 | 0.120 |
Why?
|
| Receptors, Cell Surface | 4 | 2006 | 2817 | 0.120 |
Why?
|
| International Cooperation | 2 | 2019 | 1432 | 0.120 |
Why?
|
| Membrane Glycoproteins | 5 | 2014 | 3690 | 0.120 |
Why?
|
| Matrix Metalloproteinase 9 | 1 | 2018 | 636 | 0.120 |
Why?
|
| Population | 1 | 2015 | 140 | 0.120 |
Why?
|
| Receptors, Chemokine | 2 | 2012 | 651 | 0.120 |
Why?
|
| Treatment Failure | 2 | 2018 | 2652 | 0.120 |
Why?
|
| Fluoroimmunoassay | 1 | 2014 | 30 | 0.120 |
Why?
|
| Phospholipase D | 1 | 2015 | 71 | 0.120 |
Why?
|
| Causality | 1 | 2021 | 1248 | 0.120 |
Why?
|
| China | 1 | 2021 | 2385 | 0.120 |
Why?
|
| Multivariate Analysis | 3 | 2016 | 12056 | 0.120 |
Why?
|
| Rats, Wistar | 1 | 2018 | 1884 | 0.110 |
Why?
|
| Communicable Diseases | 1 | 2022 | 874 | 0.110 |
Why?
|
| Enzyme-Linked Immunospot Assay | 1 | 2014 | 126 | 0.110 |
Why?
|
| Confidence Intervals | 1 | 2019 | 2910 | 0.110 |
Why?
|
| Anti-Asthmatic Agents | 3 | 2009 | 572 | 0.110 |
Why?
|
| Tuberculosis Vaccines | 1 | 2014 | 48 | 0.110 |
Why?
|
| ADP-Ribosylation Factors | 1 | 2014 | 130 | 0.110 |
Why?
|
| Iron Regulatory Protein 2 | 2 | 2013 | 43 | 0.110 |
Why?
|
| Genetic Heterogeneity | 2 | 2015 | 735 | 0.110 |
Why?
|
| Pectoralis Muscles | 1 | 2014 | 86 | 0.110 |
Why?
|
| T-Lymphocyte Subsets | 2 | 2016 | 1811 | 0.110 |
Why?
|
| Family Health | 3 | 2014 | 1253 | 0.110 |
Why?
|
| Chemokine CXCL10 | 1 | 2014 | 310 | 0.100 |
Why?
|
| Air Pollution, Indoor | 1 | 2020 | 931 | 0.100 |
Why?
|
| Rhinitis, Allergic, Perennial | 1 | 2013 | 57 | 0.100 |
Why?
|
| Interleukin-13 | 2 | 2007 | 388 | 0.100 |
Why?
|
| Contact Tracing | 1 | 2015 | 274 | 0.100 |
Why?
|
| Calcium Channels, L-Type | 1 | 2014 | 242 | 0.100 |
Why?
|
| RNA, Viral | 2 | 2016 | 2864 | 0.100 |
Why?
|
| Base Sequence | 2 | 2022 | 12403 | 0.100 |
Why?
|
| Chromosomes, Human, Pair 19 | 2 | 2011 | 350 | 0.100 |
Why?
|
| Reproducibility of Results | 4 | 2024 | 20124 | 0.100 |
Why?
|
| Basic Helix-Loop-Helix Leucine Zipper Transcription Factors | 1 | 2015 | 323 | 0.100 |
Why?
|
| Parents | 3 | 2019 | 3592 | 0.100 |
Why?
|
| HLA-DQ Antigens | 1 | 2012 | 190 | 0.100 |
Why?
|
| Risk Factors | 11 | 2024 | 74840 | 0.100 |
Why?
|
| Adrenergic beta-2 Receptor Agonists | 1 | 2013 | 109 | 0.100 |
Why?
|
| Homeodomain Proteins | 2 | 2012 | 2428 | 0.100 |
Why?
|
| Travel | 1 | 2018 | 806 | 0.100 |
Why?
|
| Young Adult | 18 | 2019 | 59889 | 0.100 |
Why?
|
| Transcription Factors | 4 | 2015 | 12131 | 0.100 |
Why?
|
| Blood Group Antigens | 1 | 2013 | 183 | 0.100 |
Why?
|
| Aged, 80 and over | 15 | 2022 | 59489 | 0.100 |
Why?
|
| Transients and Migrants | 1 | 2014 | 170 | 0.100 |
Why?
|
| Adolescent | 20 | 2022 | 88835 | 0.100 |
Why?
|
| Atrial Natriuretic Factor | 2 | 2010 | 348 | 0.100 |
Why?
|
| World Health Organization | 1 | 2018 | 1328 | 0.100 |
Why?
|
| Chondroitin Sulfate Proteoglycans | 1 | 2012 | 142 | 0.100 |
Why?
|
| Sample Size | 3 | 2009 | 845 | 0.100 |
Why?
|
| Chromosomes, Human | 1 | 2013 | 437 | 0.090 |
Why?
|
| Radiography, Thoracic | 1 | 2018 | 1315 | 0.090 |
Why?
|
| Likelihood Functions | 2 | 2012 | 993 | 0.090 |
Why?
|
| Introns | 3 | 2009 | 966 | 0.090 |
Why?
|
| Epistasis, Genetic | 1 | 2013 | 353 | 0.090 |
Why?
|
| beta-Defensins | 1 | 2011 | 58 | 0.090 |
Why?
|
| Obesity | 3 | 2009 | 13076 | 0.090 |
Why?
|
| Influenza, Human | 1 | 2022 | 1539 | 0.090 |
Why?
|
| Toll-Like Receptor 1 | 1 | 2011 | 48 | 0.090 |
Why?
|
| Interleukin-10 | 3 | 2009 | 1183 | 0.090 |
Why?
|
| Skin Tests | 2 | 2010 | 630 | 0.090 |
Why?
|
| Receptors, G-Protein-Coupled | 3 | 2010 | 1242 | 0.090 |
Why?
|
| Drug Therapy, Combination | 2 | 2018 | 6309 | 0.090 |
Why?
|
| Survival Analysis | 1 | 2004 | 10070 | 0.090 |
Why?
|
| Virus Replication | 2 | 2012 | 2447 | 0.090 |
Why?
|
| Recombination, Genetic | 1 | 2015 | 1525 | 0.090 |
Why?
|
| CD8-Positive T-Lymphocytes | 5 | 2012 | 4642 | 0.090 |
Why?
|
| Receptors, Corticotropin-Releasing Hormone | 2 | 2008 | 88 | 0.090 |
Why?
|
| Tumor Necrosis Factor-alpha | 3 | 2014 | 4348 | 0.090 |
Why?
|
| Chromosomes, Human, Pair 16 | 1 | 2012 | 340 | 0.090 |
Why?
|
| S100 Proteins | 1 | 2011 | 217 | 0.090 |
Why?
|
| Immunoglobulin E | 3 | 2023 | 1481 | 0.090 |
Why?
|
| Chromosomes, Human, Pair 10 | 2 | 2012 | 274 | 0.090 |
Why?
|
| Matrix Metalloproteinase 12 | 1 | 2009 | 45 | 0.080 |
Why?
|
| Candida albicans | 1 | 2013 | 377 | 0.080 |
Why?
|
| NF-kappa B | 1 | 2018 | 2485 | 0.080 |
Why?
|
| Glutamate Decarboxylase | 1 | 2010 | 240 | 0.080 |
Why?
|
| Seafood | 1 | 2013 | 395 | 0.080 |
Why?
|
| Serine Proteinase Inhibitors | 1 | 2011 | 173 | 0.080 |
Why?
|
| Fishes | 1 | 2013 | 606 | 0.080 |
Why?
|
| Adrenergic beta-Agonists | 2 | 2008 | 345 | 0.080 |
Why?
|
| Genes, Homeobox | 1 | 2010 | 287 | 0.080 |
Why?
|
| Receptors, Glucocorticoid | 1 | 2011 | 308 | 0.080 |
Why?
|
| Cyclic Nucleotide Phosphodiesterases, Type 4 | 1 | 2009 | 42 | 0.080 |
Why?
|
| Immunocompromised Host | 1 | 2014 | 866 | 0.080 |
Why?
|
| CD4-Positive T-Lymphocytes | 2 | 2013 | 4405 | 0.080 |
Why?
|
| Severity of Illness Index | 7 | 2018 | 15880 | 0.080 |
Why?
|
| Gastrointestinal Neoplasms | 1 | 2017 | 961 | 0.080 |
Why?
|
| Interleukin-1 Receptor-Associated Kinases | 1 | 2009 | 75 | 0.080 |
Why?
|
| Heart Diseases | 3 | 2010 | 2821 | 0.080 |
Why?
|
| Lectins, C-Type | 1 | 2012 | 592 | 0.080 |
Why?
|
| Lipopolysaccharides | 1 | 2016 | 2216 | 0.080 |
Why?
|
| Integrin beta3 | 1 | 2009 | 120 | 0.080 |
Why?
|
| Antigens, Bacterial | 3 | 2014 | 1146 | 0.080 |
Why?
|
| Mutation | 4 | 2021 | 30198 | 0.080 |
Why?
|
| Longitudinal Studies | 8 | 2019 | 14751 | 0.080 |
Why?
|
| Membrane Proteins | 4 | 2009 | 7851 | 0.080 |
Why?
|
| Chemokines | 1 | 2012 | 956 | 0.080 |
Why?
|
| Costa Rica | 3 | 2019 | 186 | 0.080 |
Why?
|
| Health Resources | 1 | 2014 | 949 | 0.070 |
Why?
|
| Spirometry | 3 | 2022 | 929 | 0.070 |
Why?
|
| Ventricular Dysfunction | 1 | 2009 | 143 | 0.070 |
Why?
|
| Child, Preschool | 11 | 2019 | 42500 | 0.070 |
Why?
|
| Spouses | 1 | 2010 | 288 | 0.070 |
Why?
|
| Arginase | 1 | 2008 | 81 | 0.070 |
Why?
|
| Immunologic Tests | 1 | 2008 | 101 | 0.070 |
Why?
|
| Population Groups | 1 | 2009 | 209 | 0.070 |
Why?
|
| DEAD-box RNA Helicases | 1 | 2011 | 384 | 0.070 |
Why?
|
| Indians, Central American | 1 | 2007 | 19 | 0.070 |
Why?
|
| Data Collection | 2 | 2014 | 3318 | 0.070 |
Why?
|
| Receptors, Dopamine D5 | 1 | 2007 | 32 | 0.070 |
Why?
|
| HIV Seropositivity | 1 | 2013 | 961 | 0.070 |
Why?
|
| Leukocytes, Mononuclear | 1 | 2014 | 1857 | 0.070 |
Why?
|
| Receptors, Dopamine D4 | 1 | 2008 | 168 | 0.070 |
Why?
|
| Apolipoprotein E2 | 1 | 2007 | 133 | 0.070 |
Why?
|
| Databases, Factual | 1 | 2022 | 8067 | 0.070 |
Why?
|
| Bronchial Hyperreactivity | 2 | 2005 | 300 | 0.070 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 1 | 2014 | 1657 | 0.070 |
Why?
|
| Antigens, Surface | 1 | 2011 | 1617 | 0.070 |
Why?
|
| False Positive Reactions | 1 | 2009 | 955 | 0.070 |
Why?
|
| Drug Costs | 1 | 2014 | 1193 | 0.070 |
Why?
|
| Logistic Models | 5 | 2016 | 13266 | 0.060 |
Why?
|
| Anti-Retroviral Agents | 1 | 2016 | 1787 | 0.060 |
Why?
|
| RNA, Messenger | 4 | 2014 | 12768 | 0.060 |
Why?
|
| Frizzled Receptors | 1 | 2006 | 86 | 0.060 |
Why?
|
| Chromosomes, Human, Pair 4 | 3 | 2015 | 378 | 0.060 |
Why?
|
| Recombinant Fusion Proteins | 1 | 2014 | 3737 | 0.060 |
Why?
|
| Interleukin-1 | 1 | 2009 | 1243 | 0.060 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 2 | 2009 | 3807 | 0.060 |
Why?
|
| Lymphotoxin-alpha | 1 | 2005 | 94 | 0.060 |
Why?
|
| Social Environment | 1 | 2010 | 1011 | 0.060 |
Why?
|
| Prospective Studies | 6 | 2022 | 54802 | 0.060 |
Why?
|
| Obsessive-Compulsive Disorder | 1 | 2014 | 1484 | 0.060 |
Why?
|
| Promoter Regions, Genetic | 4 | 2009 | 5786 | 0.060 |
Why?
|
| Maximal Midexpiratory Flow Rate | 1 | 2004 | 75 | 0.060 |
Why?
|
| Serpins | 1 | 2006 | 245 | 0.060 |
Why?
|
| Computer Graphics | 1 | 2006 | 344 | 0.060 |
Why?
|
| Treatment Outcome | 8 | 2018 | 65188 | 0.060 |
Why?
|
| Glucocorticoids | 2 | 2011 | 2132 | 0.060 |
Why?
|
| Chromosomes, Human, Pair 6 | 1 | 2005 | 371 | 0.060 |
Why?
|
| Incidence | 4 | 2018 | 21480 | 0.060 |
Why?
|
| Cooperative Behavior | 2 | 2014 | 1509 | 0.060 |
Why?
|
| Disease Progression | 2 | 2018 | 13632 | 0.060 |
Why?
|
| Computational Biology | 2 | 2014 | 3559 | 0.050 |
Why?
|
| Penetrance | 2 | 2017 | 388 | 0.050 |
Why?
|
| Chromosomes, Human, Pair 8 | 1 | 2005 | 451 | 0.050 |
Why?
|
| Exons | 1 | 2009 | 2391 | 0.050 |
Why?
|
| Repressor Proteins | 1 | 2014 | 2968 | 0.050 |
Why?
|
| Apolipoprotein E4 | 1 | 2007 | 708 | 0.050 |
Why?
|
| Sex Characteristics | 1 | 2013 | 2643 | 0.050 |
Why?
|
| Chromosomes, Human, Pair 5 | 1 | 2004 | 386 | 0.050 |
Why?
|
| Disease | 1 | 2008 | 676 | 0.050 |
Why?
|
| Diagnosis, Differential | 1 | 2018 | 12976 | 0.050 |
Why?
|
| Oxygen | 1 | 2014 | 4241 | 0.050 |
Why?
|
| Tomography, X-Ray Computed | 2 | 2018 | 20659 | 0.050 |
Why?
|
| Staphylococcus aureus | 1 | 2011 | 1424 | 0.050 |
Why?
|
| Blood Pressure | 1 | 2018 | 8532 | 0.050 |
Why?
|
| Bipolar Disorder | 3 | 2012 | 5138 | 0.050 |
Why?
|
| Eosinophilia | 1 | 2007 | 556 | 0.050 |
Why?
|
| Receptors, Adrenergic, beta-2 | 1 | 2003 | 216 | 0.050 |
Why?
|
| Dithionitrobenzoic Acid | 1 | 2022 | 22 | 0.050 |
Why?
|
| Metalloendopeptidases | 1 | 2004 | 386 | 0.050 |
Why?
|
| Fathers | 1 | 2005 | 376 | 0.050 |
Why?
|
| Cytotoxicity, Immunologic | 2 | 2004 | 1347 | 0.050 |
Why?
|
| Prognosis | 2 | 2021 | 29922 | 0.050 |
Why?
|
| Age Factors | 2 | 2010 | 18380 | 0.050 |
Why?
|
| Follow-Up Studies | 5 | 2016 | 39193 | 0.050 |
Why?
|
| Immunophenotyping | 2 | 2004 | 1866 | 0.050 |
Why?
|
| Chromosomes, Human, Pair 12 | 1 | 2003 | 430 | 0.050 |
Why?
|
| Wnt Proteins | 1 | 2006 | 722 | 0.050 |
Why?
|
| Receptors, Calcitriol | 1 | 2004 | 361 | 0.050 |
Why?
|
| Staphylococcal Infections | 1 | 2011 | 1393 | 0.050 |
Why?
|
| Interleukin-12 | 1 | 2004 | 579 | 0.050 |
Why?
|
| Dendritic Cells | 1 | 2013 | 2747 | 0.050 |
Why?
|
| Cytokines | 2 | 2014 | 7421 | 0.050 |
Why?
|
| Immunosuppressive Agents | 1 | 2014 | 4209 | 0.050 |
Why?
|
| Respiration | 1 | 2008 | 1653 | 0.050 |
Why?
|
| Homozygote | 3 | 2011 | 1775 | 0.050 |
Why?
|
| Multicenter Studies as Topic | 3 | 2015 | 1731 | 0.050 |
Why?
|
| Eosinophils | 2 | 2023 | 945 | 0.050 |
Why?
|
| Respiratory Function Tests | 3 | 2014 | 1693 | 0.040 |
Why?
|
| Pandemics | 1 | 2021 | 8703 | 0.040 |
Why?
|
| Crosses, Genetic | 1 | 2001 | 752 | 0.040 |
Why?
|
| Natriuretic Peptide, Brain | 1 | 2009 | 1736 | 0.040 |
Why?
|
| Cytomegalovirus | 2 | 2002 | 751 | 0.040 |
Why?
|
| Metalloproteases | 1 | 2020 | 61 | 0.040 |
Why?
|
| Coronary Artery Bypass | 1 | 2009 | 2186 | 0.040 |
Why?
|
| Cystic Fibrosis | 1 | 2009 | 1287 | 0.040 |
Why?
|
| Chi-Square Distribution | 2 | 2002 | 3432 | 0.040 |
Why?
|
| Skin | 1 | 2013 | 4489 | 0.040 |
Why?
|
| X Chromosome | 1 | 2023 | 819 | 0.040 |
Why?
|
| Herpesvirus 4, Human | 2 | 2002 | 1078 | 0.040 |
Why?
|
| Internet | 1 | 2011 | 3106 | 0.040 |
Why?
|
| Capreomycin | 1 | 2018 | 14 | 0.040 |
Why?
|
| Interferons | 1 | 2022 | 714 | 0.040 |
Why?
|
| Amikacin | 1 | 2018 | 48 | 0.040 |
Why?
|
| Kanamycin | 1 | 2018 | 63 | 0.040 |
Why?
|
| Respiratory Physiological Phenomena | 1 | 2019 | 190 | 0.040 |
Why?
|
| Anti-HIV Agents | 1 | 2014 | 4559 | 0.040 |
Why?
|
| Biomedical Research | 1 | 2014 | 3458 | 0.040 |
Why?
|
| Chromosomes, Human, Pair 9 | 2 | 2014 | 533 | 0.040 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2022 | 12240 | 0.040 |
Why?
|
| Analysis of Variance | 2 | 2003 | 6203 | 0.040 |
Why?
|
| DNA Mutational Analysis | 2 | 2018 | 4108 | 0.040 |
Why?
|
| Memory | 1 | 2007 | 2190 | 0.040 |
Why?
|
| Fungi | 1 | 2020 | 348 | 0.040 |
Why?
|
| Zinc Fingers | 1 | 2020 | 576 | 0.040 |
Why?
|
| Time Factors | 2 | 2017 | 40065 | 0.040 |
Why?
|
| Carbapenems | 1 | 2018 | 125 | 0.040 |
Why?
|
| DNA | 2 | 2009 | 7202 | 0.040 |
Why?
|
| Randomized Controlled Trials as Topic | 3 | 2010 | 10383 | 0.030 |
Why?
|
| Cross-Sectional Studies | 4 | 2014 | 26318 | 0.030 |
Why?
|
| Fibroblast Growth Factors | 1 | 2023 | 871 | 0.030 |
Why?
|
| Protease Nexins | 2 | 2006 | 39 | 0.030 |
Why?
|
| Cell Division | 1 | 2004 | 4475 | 0.030 |
Why?
|
| Fluoroquinolones | 1 | 2018 | 307 | 0.030 |
Why?
|
| Cell Line | 1 | 2010 | 15543 | 0.030 |
Why?
|
| Lymphocyte Activation | 2 | 2004 | 5501 | 0.030 |
Why?
|
| Transforming Growth Factor beta | 1 | 2004 | 1995 | 0.030 |
Why?
|
| Meat | 1 | 2019 | 588 | 0.030 |
Why?
|
| Diabetes Mellitus, Type 1 | 1 | 2011 | 3446 | 0.030 |
Why?
|
| Austria | 1 | 2016 | 206 | 0.030 |
Why?
|
| Proteins | 1 | 2010 | 5995 | 0.030 |
Why?
|
| Cognition | 1 | 2013 | 7049 | 0.030 |
Why?
|
| Clinical Trials as Topic | 4 | 2013 | 8041 | 0.030 |
Why?
|
| Cachexia | 1 | 2017 | 200 | 0.030 |
Why?
|
| Mycoses | 1 | 2018 | 389 | 0.030 |
Why?
|
| Alcoholism | 1 | 2005 | 1975 | 0.030 |
Why?
|
| Diet | 1 | 2013 | 8086 | 0.030 |
Why?
|
| Colorectal Neoplasms | 1 | 2014 | 6942 | 0.030 |
Why?
|
| Receptor-Like Protein Tyrosine Phosphatases, Class 2 | 1 | 2014 | 21 | 0.030 |
Why?
|
| Untranslated Regions | 1 | 2014 | 30 | 0.030 |
Why?
|
| Gene Expression Profiling | 4 | 2014 | 9525 | 0.030 |
Why?
|
| ADAM Proteins | 2 | 2007 | 242 | 0.030 |
Why?
|
| Odds Ratio | 3 | 2013 | 9649 | 0.030 |
Why?
|
| Depressive Disorder, Major | 1 | 2012 | 4808 | 0.030 |
Why?
|
| Mutation, Missense | 2 | 2014 | 2589 | 0.030 |
Why?
|
| Animals | 6 | 2018 | 168764 | 0.030 |
Why?
|
| European Union | 1 | 2014 | 157 | 0.030 |
Why?
|
| Antigens, CD | 1 | 2004 | 4025 | 0.030 |
Why?
|
| Bone Morphogenetic Protein 4 | 1 | 2014 | 163 | 0.030 |
Why?
|
| Proto-Oncogene Proteins | 1 | 2006 | 4520 | 0.030 |
Why?
|
| Boston | 2 | 2017 | 9338 | 0.030 |
Why?
|
| Cell Cycle Proteins | 1 | 2005 | 3430 | 0.030 |
Why?
|
| Immune Tolerance | 1 | 2002 | 2324 | 0.030 |
Why?
|
| Pore Forming Cytotoxic Proteins | 2 | 2004 | 128 | 0.030 |
Why?
|
| Risk Assessment | 4 | 2019 | 24282 | 0.030 |
Why?
|
| Reference Standards | 1 | 2017 | 1013 | 0.030 |
Why?
|
| Injections, Intradermal | 1 | 2013 | 116 | 0.030 |
Why?
|
| Hypersensitivity | 1 | 2002 | 1168 | 0.030 |
Why?
|
| Drosophila Proteins | 1 | 2002 | 1697 | 0.030 |
Why?
|
| Perforin | 2 | 2004 | 166 | 0.030 |
Why?
|
| Chemokine CCL4 | 1 | 2012 | 124 | 0.030 |
Why?
|
| Dyspnea | 1 | 2021 | 1352 | 0.030 |
Why?
|
| Body Composition | 2 | 2014 | 2439 | 0.030 |
Why?
|
| Chemoprevention | 1 | 2015 | 327 | 0.030 |
Why?
|
| Flow Cytometry | 2 | 2016 | 5881 | 0.030 |
Why?
|
| Chromosomes, Human, Pair 17 | 1 | 2014 | 416 | 0.030 |
Why?
|
| Neurocan | 1 | 2012 | 21 | 0.030 |
Why?
|
| Age Distribution | 1 | 2018 | 2858 | 0.030 |
Why?
|
| Bronchoalveolar Lavage | 1 | 2012 | 131 | 0.030 |
Why?
|
| Brain | 2 | 2012 | 27171 | 0.020 |
Why?
|
| Immunity, Innate | 3 | 2011 | 3081 | 0.020 |
Why?
|
| Chemokine CCL5 | 1 | 2012 | 213 | 0.020 |
Why?
|
| Chronic Disease | 2 | 2004 | 9347 | 0.020 |
Why?
|
| Drug Resistance, Multiple, Bacterial | 1 | 2016 | 592 | 0.020 |
Why?
|
| Tumor Suppressor Proteins | 1 | 2022 | 2796 | 0.020 |
Why?
|
| ROC Curve | 2 | 2010 | 3620 | 0.020 |
Why?
|
| Sensitivity and Specificity | 3 | 2014 | 14652 | 0.020 |
Why?
|
| Vaccination | 1 | 2004 | 3426 | 0.020 |
Why?
|
| Oximetry | 1 | 2014 | 459 | 0.020 |
Why?
|
| Chromosomes, Human, Pair 7 | 1 | 2012 | 311 | 0.020 |
Why?
|
| Macrophages | 1 | 2006 | 5772 | 0.020 |
Why?
|
| Infant | 2 | 2015 | 36386 | 0.020 |
Why?
|
| Gene Duplication | 1 | 2012 | 317 | 0.020 |
Why?
|
| Histone Deacetylase 1 | 1 | 2011 | 132 | 0.020 |
Why?
|
| Open Reading Frames | 1 | 2014 | 820 | 0.020 |
Why?
|
| Denmark | 1 | 2013 | 774 | 0.020 |
Why?
|
| Receptors, CCR5 | 1 | 2012 | 491 | 0.020 |
Why?
|
| DNA-Binding Proteins | 1 | 2007 | 9601 | 0.020 |
Why?
|
| Ghana | 1 | 2011 | 333 | 0.020 |
Why?
|
| Africa South of the Sahara | 1 | 2012 | 751 | 0.020 |
Why?
|
| Myocardial Infarction | 1 | 2010 | 11499 | 0.020 |
Why?
|
| GTPase-Activating Proteins | 1 | 2013 | 465 | 0.020 |
Why?
|
| Microbial Sensitivity Tests | 1 | 2016 | 1971 | 0.020 |
Why?
|
| Genetic Complementation Test | 1 | 2010 | 557 | 0.020 |
Why?
|
| Calcium Signaling | 1 | 2014 | 733 | 0.020 |
Why?
|
| Rest | 1 | 2014 | 942 | 0.020 |
Why?
|
| Receptors, Nicotinic | 1 | 2013 | 494 | 0.020 |
Why?
|
| Receptors, Atrial Natriuretic Factor | 1 | 2009 | 42 | 0.020 |
Why?
|
| Norway | 1 | 2010 | 499 | 0.020 |
Why?
|
| Biopsy | 2 | 2011 | 6763 | 0.020 |
Why?
|
| Respiratory Sounds | 1 | 2013 | 705 | 0.020 |
Why?
|
| Gene Expression Regulation | 3 | 2014 | 11888 | 0.020 |
Why?
|
| Ecology | 1 | 2009 | 105 | 0.020 |
Why?
|
| Membrane Transport Proteins | 1 | 2014 | 1028 | 0.020 |
Why?
|
| Epithelial Cells | 2 | 2011 | 3681 | 0.020 |
Why?
|
| Demography | 1 | 2013 | 1641 | 0.020 |
Why?
|
| Theophylline | 1 | 2008 | 132 | 0.020 |
Why?
|
| Auditory Perceptual Disorders | 1 | 2008 | 36 | 0.020 |
Why?
|
| Consensus | 1 | 2018 | 3202 | 0.020 |
Why?
|
| Enhancer Elements, Genetic | 1 | 2014 | 1365 | 0.020 |
Why?
|
| Patient-Centered Care | 1 | 2018 | 1458 | 0.020 |
Why?
|
| Protein Isoforms | 1 | 2012 | 1718 | 0.020 |
Why?
|
| Neuropsychological Tests | 2 | 2013 | 7123 | 0.020 |
Why?
|
| South Africa | 1 | 2013 | 1867 | 0.020 |
Why?
|
| Gene Order | 1 | 2007 | 164 | 0.020 |
Why?
|
| Metagenomics | 1 | 2011 | 473 | 0.020 |
Why?
|
| Albuterol | 1 | 2008 | 211 | 0.020 |
Why?
|
| Chromosome Deletion | 1 | 2012 | 1385 | 0.020 |
Why?
|
| Dipeptidyl-Peptidases and Tripeptidyl-Peptidases | 1 | 2007 | 88 | 0.020 |
Why?
|
| Lysine | 1 | 2011 | 991 | 0.020 |
Why?
|
| Potassium Channels, Inwardly Rectifying | 1 | 2007 | 145 | 0.020 |
Why?
|
| Immunohistochemistry | 2 | 2013 | 11022 | 0.020 |
Why?
|
| Immunologic Memory | 1 | 2013 | 1375 | 0.020 |
Why?
|
| Inflammation | 1 | 2006 | 10850 | 0.020 |
Why?
|
| Stem Cell Transplantation | 1 | 2014 | 1602 | 0.020 |
Why?
|
| Cystic Fibrosis Transmembrane Conductance Regulator | 1 | 2009 | 452 | 0.020 |
Why?
|
| Microarray Analysis | 1 | 2009 | 752 | 0.020 |
Why?
|
| Sex Factors | 1 | 2020 | 10603 | 0.020 |
Why?
|
| Syndrome | 1 | 2012 | 3271 | 0.020 |
Why?
|
| Recurrence | 1 | 2018 | 8501 | 0.020 |
Why?
|
| Administration, Inhalation | 1 | 2009 | 1154 | 0.020 |
Why?
|
| Societies, Medical | 1 | 2018 | 3956 | 0.020 |
Why?
|
| Ligands | 1 | 2012 | 3273 | 0.020 |
Why?
|
| Area Under Curve | 1 | 2010 | 1638 | 0.020 |
Why?
|
| Arachidonate 5-Lipoxygenase | 1 | 2006 | 128 | 0.020 |
Why?
|
| Leukotriene Antagonists | 1 | 2006 | 124 | 0.020 |
Why?
|
| Siblings | 1 | 2009 | 828 | 0.020 |
Why?
|
| Environmental Exposure | 1 | 2020 | 4544 | 0.020 |
Why?
|
| Receptors, Adrenergic, beta | 1 | 2006 | 242 | 0.020 |
Why?
|
| Pulmonary Surfactant-Associated Protein B | 1 | 2005 | 44 | 0.020 |
Why?
|
| Lod Score | 1 | 2005 | 598 | 0.020 |
Why?
|
| Toll-Like Receptor 10 | 1 | 2004 | 12 | 0.010 |
Why?
|
| Surgical Procedures, Operative | 1 | 2016 | 1941 | 0.010 |
Why?
|
| Epoxy Compounds | 1 | 2005 | 136 | 0.010 |
Why?
|
| Interleukin-12 Subunit p40 | 1 | 2004 | 58 | 0.010 |
Why?
|
| Heme Oxygenase (Decyclizing) | 1 | 2005 | 165 | 0.010 |
Why?
|
| Troponin I | 1 | 2009 | 655 | 0.010 |
Why?
|
| Quebec | 1 | 2004 | 140 | 0.010 |
Why?
|
| Epoxide Hydrolases | 1 | 2005 | 121 | 0.010 |
Why?
|
| Organ Transplantation | 1 | 2014 | 1174 | 0.010 |
Why?
|
| Combined Modality Therapy | 1 | 2016 | 8529 | 0.010 |
Why?
|
| Cadherins | 1 | 2008 | 900 | 0.010 |
Why?
|
| Serine Endopeptidases | 1 | 2009 | 1024 | 0.010 |
Why?
|
| Mixed Function Oxygenases | 1 | 2005 | 265 | 0.010 |
Why?
|
| Heterozygote | 1 | 2010 | 2794 | 0.010 |
Why?
|
| Placebos | 1 | 2008 | 1659 | 0.010 |
Why?
|
| Task Performance and Analysis | 1 | 2007 | 770 | 0.010 |
Why?
|
| United States | 3 | 2013 | 72903 | 0.010 |
Why?
|
| Genes, Recessive | 1 | 2006 | 624 | 0.010 |
Why?
|
| Repetitive Sequences, Nucleic Acid | 1 | 2005 | 780 | 0.010 |
Why?
|
| Gene Expression Regulation, Developmental | 1 | 2014 | 3607 | 0.010 |
Why?
|
| Antigen-Presenting Cells | 1 | 2006 | 962 | 0.010 |
Why?
|
| Chromatin | 1 | 2014 | 2980 | 0.010 |
Why?
|
| Mothers | 1 | 2013 | 2210 | 0.010 |
Why?
|
| Respiratory Hypersensitivity | 1 | 2004 | 271 | 0.010 |
Why?
|
| Kidney Failure, Chronic | 1 | 2014 | 2495 | 0.010 |
Why?
|
| Double-Blind Method | 2 | 2008 | 12437 | 0.010 |
Why?
|
| HLA Antigens | 1 | 2007 | 1339 | 0.010 |
Why?
|
| Cloning, Molecular | 1 | 2007 | 4165 | 0.010 |
Why?
|
| 3' Untranslated Regions | 1 | 2004 | 515 | 0.010 |
Why?
|
| ATP-Binding Cassette Transporters | 1 | 2005 | 568 | 0.010 |
Why?
|
| Chromosomes, Human, Pair 1 | 1 | 2004 | 640 | 0.010 |
Why?
|
| Health Care Costs | 1 | 2014 | 3242 | 0.010 |
Why?
|
| Medical History Taking | 1 | 2005 | 777 | 0.010 |
Why?
|
| Self Report | 1 | 2013 | 3770 | 0.010 |
Why?
|
| Receptors, CCR7 | 1 | 2001 | 104 | 0.010 |
Why?
|
| Microsatellite Repeats | 1 | 2003 | 784 | 0.010 |
Why?
|
| L-Selectin | 1 | 2001 | 212 | 0.010 |
Why?
|
| Amino Acid Sequence | 1 | 2012 | 13400 | 0.010 |
Why?
|
| Histones | 1 | 2011 | 2584 | 0.010 |
Why?
|
| Histocompatibility Antigens Class I | 1 | 2007 | 1365 | 0.010 |
Why?
|
| Epitopes, T-Lymphocyte | 1 | 2004 | 825 | 0.010 |
Why?
|
| Lymphocyte Subsets | 1 | 2001 | 315 | 0.010 |
Why?
|
| Molecular Sequence Data | 1 | 2012 | 17594 | 0.010 |
Why?
|
| Body Weight | 1 | 2010 | 4622 | 0.010 |
Why?
|
| Lymphatic Diseases | 1 | 2001 | 317 | 0.010 |
Why?
|
| Anti-Inflammatory Agents | 1 | 2009 | 1808 | 0.010 |
Why?
|
| Arthritis, Rheumatoid | 1 | 2014 | 3733 | 0.010 |
Why?
|
| Toll-Like Receptors | 1 | 2002 | 583 | 0.010 |
Why?
|
| Toll-Like Receptor 4 | 1 | 2002 | 586 | 0.010 |
Why?
|
| Retrospective Studies | 3 | 2016 | 81514 | 0.010 |
Why?
|
| Mental Disorders | 1 | 2018 | 6853 | 0.010 |
Why?
|
| Massachusetts | 1 | 2010 | 8875 | 0.010 |
Why?
|
| Predictive Value of Tests | 1 | 2014 | 15398 | 0.010 |
Why?
|
| Signal Transduction | 2 | 2014 | 23601 | 0.010 |
Why?
|
| Reference Values | 1 | 2004 | 4908 | 0.010 |
Why?
|
| Health Services Accessibility | 1 | 2014 | 5508 | 0.010 |
Why?
|
| Up-Regulation | 1 | 2006 | 4137 | 0.010 |
Why?
|
| Monocytes | 1 | 2006 | 2595 | 0.010 |
Why?
|
| Virus Diseases | 1 | 2002 | 718 | 0.010 |
Why?
|
| HIV | 1 | 2002 | 1585 | 0.010 |
Why?
|
| Allergens | 1 | 2002 | 1436 | 0.010 |
Why?
|
| Infant, Newborn | 1 | 2015 | 26346 | 0.010 |
Why?
|
| Adaptor Proteins, Signal Transducing | 1 | 2005 | 2900 | 0.010 |
Why?
|
| Cognition Disorders | 1 | 2007 | 3967 | 0.010 |
Why?
|
| Polymerase Chain Reaction | 1 | 2002 | 6069 | 0.010 |
Why?
|
| Hospitalization | 1 | 2013 | 10808 | 0.010 |
Why?
|
| Insulin | 1 | 2007 | 6599 | 0.010 |
Why?
|
| Transcription, Genetic | 1 | 2005 | 7599 | 0.010 |
Why?
|
| Pregnancy | 1 | 2013 | 30260 | 0.010 |
Why?
|
| Mice | 2 | 2006 | 81819 | 0.000 |
Why?
|
| Practice Guidelines as Topic | 1 | 2006 | 7425 | 0.000 |
Why?
|
| Apoptosis | 1 | 2004 | 9514 | 0.000 |
Why?
|
| Cell Differentiation | 1 | 2004 | 11641 | 0.000 |
Why?
|